Study: Myriad myRisk Hereditary Cancer test identifies 43 percent more patients with
Myriad Genetics, Inc. has announced that the Myriad myRisk™ Hereditary Cancer test significantly improved the detection of cancer-causing mutations by 46 percent in patients with breast...